ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

$1.11
+0.08 (+7.77%)
As of Sep 28, 10:49 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +228.8% upside
Low Target $2.40
Average Target $3.65
High Target $4.80
Current Price $1.11
Current
$1.11
Target
$3.65
$2.40 $3.65 avg $4.80
Scenario Analysis
Bear Case
$2.40
116.2%
Low target
Base Case
$3.65
+228.8%
Avg target
Bull Case
$4.80
+332.4%
High target
Risk/Reward
2.9x
Favorable
Price in Context
Target vs 52W High
$3.65
-98.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%